Form D · Biotechnology

FENNEC PHARMACEUTICALS INC.

Research Triangle Park, NC · CIK 0001211583

Offering snapshot reported Jun 8, 2017 · SEC filing

Reported sold
$7.6M
Offering amount: $7.6M
Investors reported
7
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 8, 2017
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 8, 2017Initial$7,600,000No comparison7SEC filing
Dec 15, 2014Initial$2,200,000No comparison22SEC filing
Nov 27, 2013Initial$1,600,000No comparison8SEC filing
Mar 7, 2007PaperNot reportedNo comparisonNot reportedSEC filing
May 23, 2006PaperNot reportedNo comparisonNot reported
Jul 29, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-288353
1,900,000 shares of Common Stock

Source: Form D, filed Jun 8, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Adrian Haigh Director
Khalid Islam Director
Krysia Lynes Executive
Chris Rallis Director
Rostislav Raykov Director, Executive
Rotislav Raykov Director, Executive
Steven Skolsky Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
68 Tw Alexander Drive
Research Triangle Park, NC, 27709